companydata.dkcompanydata.dk

Vesper Bio ApS: Financial statements 2021

CVR: 32879861

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -13,498,842 and a net result of DKK -16,471,481 compared with DKK -7,955,052 the year before. Equity in the 2021 report amounted to DKK -23,302,583.

Gross Profit
DKK -13,498,842
Profit/Loss
DKK -16,471,481
Equity
DKK -23,302,583
Total Assets
DKK 5,275,407
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--13.5 mio.-16.5 mio.-23.3 mio.0
2020--6.8 mio.-8 mio.-6.8 mio.1
2019---2.8 mio.1.1 mio.1
2018---4 mio.3.9 mio.1
2017---2.7 mio.7.9 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Vesper Bio ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Vesper Bio ApS: The 2020 annual report is outMar 25, 2021

Vesper Bio ApS has published its annual report for 2020. Gross profit came to DKK -6,780,427, and the net result was DKK -7,955,052.

About Vesper Bio ApS

Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.

Source: annual report 2025, Danish Business Authority